DossierENTITY

Revlimid

Coverage of Revlimid in the Nexus archive.

Earliest in view: Jul 15 · 21:00 UTCMost recent: Jul 15 · 21:00 UTC

Co-mentioned in this coverage

Recent coverage

HEALTHJul 15 · 21:00 UTCMEDPAGE TODAY
Trial Questions Continuous Maintenance in Newly Diagnosed Myeloma
A phase III trial (ENDURANCE) found that continuous lenalidomide (Revlimid) maintenance therapy did not significantly improve overall survival in patients with standard-risk, newly diagnosed multiple myeloma. The results question the effectiveness of continuous maintenance in this patient group.